NCT04085640

Brief Summary

Interest of obturator nerve block for analgesia in total hip arthroplasty remains controversial. This regional anesthesia procedure could provide post-operative pain relief as obturator nerve is responsible for innervation of the internal part of the hip joint capsule. This randomized double-blind study aims to assess obturator nerve block for post-operative analgesia in total hip arthroplasty. Before the surgery, an ultrasound guided obturator nerve block will be performed with either 20cc of saline or ropivacaine 0.2% (a long-acting local anesthetics). After regional anesthesia, a general anesthesia will be performed for intraoperative period. This study aims to assess post-operative pain management during the first 24 hours. Ability to walk the day of the surgery will also be collected.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2020

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 3, 2019

Completed
8 days until next milestone

First Posted

Study publicly available on registry

September 11, 2019

Completed
4 months until next milestone

Study Start

First participant enrolled

January 14, 2020

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 22, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 22, 2020

Completed
Last Updated

December 14, 2020

Status Verified

December 1, 2020

Enrollment Period

8 months

First QC Date

September 3, 2019

Last Update Submit

December 11, 2020

Conditions

Keywords

Hip Arthroplastyregional anesthesiaobturator nerve block

Outcome Measures

Primary Outcomes (1)

  • Oxycodone requirement in PACU

    In the PACU, patients will be assessed for pain using a verbal rating scale (VRS) (VRS, 0=no pain, 10=worst pain). Patients suffering from pain (VRS \> 4/10) will receive oxycodone 2 mg intravenous boluses / 3 minutes. Oxycodone requirement will be compared between interventional and control groups.

    Length of stay in PACU

Secondary Outcomes (4)

  • Pain assessement

    Postoperative period : maximum 24 hours after surgery

  • Postoperative Oxycodone consumption

    Postoperative period : maximum 24 hours after surgery

  • Ability to walk

    Postoperative period : maximum 24 hours after surgery

  • Side effects of opioids

    Postoperative period : maximum 24 hours after surgery

Study Arms (2)

Obturator nerve block with Ropivacaine

EXPERIMENTAL

Obturator nerve block will be performed before general anesthesia as descripted by Nielsen (RAPM, 2019). A linear transducer will be oriented in the transverse plane and placed in the inguinal crease. The tail of the transducer will be tilted distal in order to visualize the pectineus muscle (medial to the femoral vessels) at its insertion at the superior pubic ramus superficial to the external obturator muscle. An 80 mm nerve block needlewill be inserted in-plane from the lateral end of the transducer and advanced until the tip of the needle will be inside the interfascial plane between the pectineus and the obturator externus muscles. 20 milliliters of ropivacaine 2 mg/mL will be injected in the interfacial plane between the pectineus and external obturator muscles.

Other: Obturator nerve block with ropivacaine 0.2%.

Obturator nerve block with isotonic salin

SHAM COMPARATOR

The same procedure will be performed and 20 milliliters of isotonic saline will be injected in the interfacial plane between the pectineus and external obturator muscles

Other: Obturator nerve block with isotonic saline

Interventions

20 milliliters of ropivacaine 2 mg/mL will be injected in the interfacial plane between the pectineus and external obturator muscles.

Obturator nerve block with Ropivacaine

20 milliliters of isotonic saline will be injected in the interfacial plane between the pectineus and external obturator muscles.

Obturator nerve block with isotonic salin

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years and older
  • Primary THA under general anesthesia
  • Consent for participation
  • Affiliation to the french social security system

You may not qualify if:

  • Revision of hip arthroplasty
  • Significant psychiatric disturbances
  • Minor patient
  • Pregnancy
  • Breastfeeding
  • Contraindication to any drug used in the protocol: acetaminophen, ketoprofen, nefopam, oxycodone, propofol, ketamine, Ropivacaine…
  • Chronic pain
  • Current use oral morphine or equivalents

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Clinique Medipole Garonne

Toulouse, 31036, France

Location

Related Publications (1)

  • Marty P, Chassery C, Rontes O, Vuillaume C, Basset B, Merouani M, Marquis C, Delussy A, Delbos MC, Ferre F, Bataille B, Joshi G, Delbos A. Obturator nerve block does not provide analgesic benefits in total hip arthroplasty under multimodal analgesic regimen: a randomized controlled trial. Reg Anesth Pain Med. 2021 Aug;46(8):657-662. doi: 10.1136/rapm-2021-102531. Epub 2021 May 5.

MeSH Terms

Interventions

Sodium Chloride

Intervention Hierarchy (Ancestors)

ChloridesHydrochloric AcidChlorine CompoundsInorganic ChemicalsSodium Compounds

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 3, 2019

First Posted

September 11, 2019

Study Start

January 14, 2020

Primary Completion

September 22, 2020

Study Completion

September 22, 2020

Last Updated

December 14, 2020

Record last verified: 2020-12

Data Sharing

IPD Sharing
Will not share

Locations